Cumberland Pharmaceuticals Inc.: capex
| Value | {"amount": 94485, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-09-30 |
| Status | current |
| Entity | Cumberland Pharmaceuticals Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:49:05.543728+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/208a7668-c279-4a5a-b174-8586a15787e3
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-21-023213Retrieved: 2026-08-19T10:49:05.543728+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001087294/capex/2021-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/208a7668-c279-4a5a-b174-8586a15787e3
History
- no predecessors — first report